SYROS PHARMACEUTICALS, INC.
Profile
Company Names
SYROS PHARMACEUTICALS, INC.
LS22, INC.
Addresses
35 CAMBRIDGE PARK DRIVE, CAMBRIDGE, MA 02140
35 CAMBRIDGEPARK DRIVE, CAMBRIDGE, MA 02140
620 MEMORIAL DRIVE, SUITE 300, CAMBRIDGE, MA 02139
480 ARSENAL STREET, SUITE 130, WATERTOWN, MA 02472
C/O FLAGSHIP VENTURES, ONE MEMORIAL DRIVE, 7TH FLOOR, CAMBRIDGE, MA 02142
Phone Numbers
617-744-1340
617-868-1888
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2011
State Incorporated:
DELAWARE
Total Amount Raised:
$296,113,360.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2022-09-16
$129,843,346.00
$129,843,346.00
$0.00
Equity
5
2020-12-08
$90,490,000.00
$121,609,375.00
$31,119,375.00
Equity
4
2018-01-08
$11,380,018.00
$11,380,018.00
$0.00
Equity
3
2014-10-09
$53,149,996.00
$53,149,996.00
$0.00
Equity
2
2013-04-10
$10,000,000.00
$12,000,000.00
$2,000,000.00
Equity
1
2012-08-08
$1,250,000.00
$1,250,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
NOUBAR
B.
AFEYAN
DIRECTOR
SRINIVAS
AKKARAJU
DIRECTOR
SEATTLE GENETICS INC /WA
| PRESIDIO PHARMACEUTICALS, INC.
| VERSARTIS, INC.
| PRINCIPIA BIOPHARMA INC.
| SYROS PHARMACEUTICALS, INC.
| SAMSARA BIOCAPITAL, L.P.
| 565 SPV I, L.P.
| TENTARIX BIOTHERAPEUTICS, LP
| CHINOOK THERAPEUTICS U.S., INC.
| MINERALYS THERAPEUTICS, INC.
| ORSOBIO, INC.
| VTV THERAPEUTICS INC.
| ALUMIS INC.
| SAMSARA OPPORTUNITY FUND, L.P.
STEPHANE
BANCEL
DIRECTOR
DOUGLAS
COLE
DIRECTOR, EXECUTIVE OFFICER
JORGE
CONDE
EXECUTIVE OFFICER
MARSHA
FANUCCI
DIRECTOR
AMIR
NASHAT
DIRECTOR
PROMEDIOR INC
| AVILA THERAPEUTICS INC
| PERVASIS THERAPEUTICS INC
| FATE THERAPEUTICS INC
| BIND BIOSCIENCES INC
| SELECTA BIOSCIENCES INC
| POLARIS VENTURE PARTNERS VI, L.P.
| SUN CATALYTIX CORP
| RECEPTOS, INC.
| POLARIS ENTREPRENEURS- FUND VII, L.P.
| POLARIS PARTNERS VII, L.P.
| ATYR PHARMA INC
| AGBIOME, LLC
| METACRINE, INC.
| SCHOLAR ROCK LLC
| 1366 TECHNOLOGIES INC
| SOFREGEN MEDICAL INC.
| POLARIS ENTREPRENEURS- FUND VIII, L.P.
| SYROS PHARMACEUTICALS, INC.
| SCHOLAR ROCK HOLDING CORP
| CAMP4 THERAPEUTICS CORP
| MORPHIC HOLDING, LLC
| FREENOME HOLDINGS, INC.
| PRIMMUNE THERAPEUTICS, INC.
| MORPHIC HOLDING, INC.
ROBERT
NELSEN
DIRECTOR
FORGE INC
| RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)
| AGIOS PHARMACEUTICALS INC
| KILIMANJARO ENERGY, INC.
| NEUROGESX INC
| KYTHERA BIOPHARMACEUTICALS INC
| SYROS PHARMACEUTICALS, INC.
| FATE THERAPEUTICS INC
| CENEXYS, INC.
| JUNO THERAPEUTICS, INC.
| BELLEROPHON THERAPEUTICS LLC
| FARADAY PHARMACEUTICALS, INC.
| SAPPHIRE ENERGY, INC.
| UNITY BIOTECHNOLOGY, INC.
| ARIVALE INC.
| SIENNA BIOPHARMACEUTICALS, INC.
| GOSSAMER BIO, INC.
| VIR BIOTECHNOLOGY, INC.
| BEAM THERAPEUTICS INC.
| GRAIL, INC.
| APEX NEURO HOLDINGS, INC.
| NUTCRACKER THERAPEUTICS, INC.
| SANA BIOTECHNOLOGY, INC.
| INSITRO, INC.
| NATIONAL RESILIENCE, INC.
| MEDICAL CREATIONS, INC.
| NEUMORA THERAPEUTICS, INC.
| RIPPL CARE, INC.
| SEAPORT THERAPEUTICS, INC.
ERIC
OLSON
EXECUTIVE OFFICER
NOVIA CARECLINICS LLC
| NOVIA CARECLINICS, LLC
| LONESTAR HEART, INC.
| TRACKINGPOINT, INC.
| CITYSCAN INC.
| ZERISTA, INC.
| SEA PHARMACEUTICALS, LLC
| CYBER RELIANT CORP.
| SYROS PHARMACEUTICALS, INC.
| SECURED FIXED INCOME FUND, LLC
| CONSENSUS NLP, INC.
| OCEAN AERO, INC.
| NEWLIGHT TECHNOLOGIES, INC.
| CONSENSUS NLP INC.
DAVID
ROTH
EXECUTIVE OFFICER
GENOMAS INC
| APPFIRST, INC.
| ICON CAPITAL CORP
| SOUTHOCEAN REAL ESTATE PARTNERS, LLC
| BLACKSTONE REAL ESTATE PARTNERS VIII L.P.
| BLACKSTONE REAL ESTATE PARTNERS VIII.F L.P.
| SO DISTRICT CO-INVEST, LLC
| BLACKSTONE EDISON MANAGED PARTNERS L.P.
| BREP EUROPE V (ALBERTA) L.P.
| BLACKSTONE REAL ESTATE PARTNERS EUROPE V L.P.
| BLACKSTONE EDISON MANAGED PARTNERS.TE L.P.
| SOUTHOCEAN REAL ESTATE PARTNERS II, LLC
| SO DAVIS CO-INVEST, LLC
| BLACKSTONE REAL ESTATE PARTNERS ASIA II L.P.
| BREP ASIA II FEEDER L.P.
| SO VTC II CO-INVEST, LLC
| SYROS PHARMACEUTICALS, INC.
| BLACKSTONE REAL ESTATE PARTNERS ASIA II (LUX) SCSP
| SO SUN VALLEY HOLDINGS, LLC
| AREG 601 W. 29 CO-INVEST MEMBER LLC
| SO BOULDER HOLDINGS, LLC
| SO MAGNOLIA CO-INVEST, LLC
| SOUTHOCEAN REAL ESTATE PARTNERS IV, LLC
| SO RALEIGH-DURHAM HOLDINGS, LLC
| ARES US REAL ESTATE OPPORTUNITY FUND III, L.P.
| ARES US REAL ESTATE OPPORTUNITY PARALLEL FUND III-A, L.P.
| SOCP WPV, LLC
| AREOF III CO-INVEST (ONSHORE), L.P.
| AREOF III CO-INVEST (OFFSHORE), L.P.
| SOUTHOCEAN REAL ESTATE PARTNERS V, LLC
| ARES US REAL ESTATE OPPORTUNITY PARALLEL FUND LLL-B, L.P.
| CORE-ARMS, LLC
| SOCP NR PARTNERS, LLC
| SO V MALLORY CO-INVEST, LLC
| NEW CARS OP LLC
| CARS MANAGEMENT CO. LLC
| ARES US REAL ESTATE FUND X, L.P.
| ARES US REAL ESTATE FUND X-A, L.P.
| ARES US REAL ESTATE FUND X-B, L.P.
| VSBLTY GROUPE TECHNOLOGIES CORP.
| SO V ADDISON PARK CO-INVEST, LLC
| SOUTHOCEAN REAL ESTATE PARTNERS VI, LLC
| ARES US REAL ESTATE OPPORTUNITY FUND IV, L.P.
| ARES US REAL ESTATE OPPORTUNITY PARALLEL FUND IV-A, L.P.
| ARES US REAL ESTATE OPPORTUNITY PARALLEL FUND IV-B, L.P.
| ARES US REAL ESTATE OPPORTUNITY PARALLEL FUND IV-B II, L.P.
| ARES US REAL ESTATE OPPORTUNITY PARALLEL FUND IV-C, L.P.
| SO V VERO + I-DRIVE CO-INVEST, LLC
| LAVIT HOLDINGS INC.
| ARES US REAL ESTATE FUND XI, L.P.
| ARES US REAL ESTATE FUND XI-A, L.P.
| ARES US REAL ESTATE FUND XI-B, L.P.
| ARES US REAL ESTATE FUND XI-C, L.P.
| LUMATI HOLDINGS, INC.
VICKI
SATO
DIRECTOR
TIMOTHY
C.
TYSON
DIRECTOR
PETER
WIRTH
DIRECTOR
RICHARD
A.
YOUNG
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-09-16
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-12-08
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-01-08
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-01-08
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
COWEN AND COMPANY, LLC
NONE
NONE
NONE
PIPER SANDLER + CO.
NONE
